The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Johnson Matthey and Meggitt receive upgrades

Fri, 30th Apr 2021 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

HSBC RAISES JOHNSON MATTHEY TO 'BUY' ('HOLD') - TARGET 3,750 (2,850) PENCE

----------

CITIGROUP RAISES WEIR GROUP PRICE TARGET TO 2,100 (1,900) PENCE - 'NEUTRAL'

----------

MORGAN STANLEY CUTS RECKITT BENCKISER PRICE TARGET TO 7,300 (7,900) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 10,400 (9,600) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES STANDARD CHARTERED PRICE TARGET TO 630 (550) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES STANDARD CHARTERED PRICE TARGET TO 730 (690) PENCE - 'BUY'

----------

BERENBERG RAISES NATWEST PRICE TARGET TO 230 (200) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS NATWEST PRICE TARGET TO 295 (300) PENCE - 'CONVICTION BUY LIST'

----------

MORGAN STANLEY RAISES NATWEST PRICE TARGET TO 250 (245) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES LLOYDS PRICE TARGET TO 55 (47) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES LLOYDS PRICE TARGET TO 54 (50) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,200 (1,150) PENCE - 'SELL'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,510 (1,550) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FLUTTER PRICE TARGET TO 16,285 (15,485) PENCE - 'HOLD'

----------

JPMORGAN CUTS FLUTTER PRICE TARGET TO 15,970 (16,233) PENCE - 'NEUTRAL'

----------

HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 330 (290) PENCE - 'BUY'

----------

HSBC RAISES AVIVA PRICE TARGET TO 420 (390) PENCE - 'HOLD'

----------

BERENBERG RAISES SMITH & NEPHEW PRICE TARGET TO 2,020 (1,985) PENCE - 'BUY'

----------

BARCLAYS RAISES SMITH & NEPHEW PRICE TARGET TO 1,800 (1,750) PENCE - 'OVERWEIGHT'

----------

SOCGEN RAISES BAE SYSTEMS PRICE TARGET TO 606 (580) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES ST JAMES'S PLACE TARGET TO 1,300 (1,250) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 2,925 (2,920) PENCE - 'SELL'

----------

BARCLAYS RAISES SCHRODERS PRICE TARGET TO 3,550 (3,430) PENCE - 'EQUAL WEIGHT'

----------

GOLDMAN SACHS RAISES UNILEVER PRICE TARGET TO 4,850 (4,800) PENCE - 'BUY'

----------

JEFFERIES RAISES UNILEVER PRICE TARGET TO 4,700 (4,550) PENCE - 'BUY'

----------

JEFFERIES RAISES ROYAL DUTCH SHELL PRICE TARGET TO 1,930 (1,890) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES ROYAL DUTCH SHELL B PRICE TARGET TO 2,100 (2,000) PENCE - 'BUY'

----------

RBC CUTS GLENCORE PRICE TARGET TO 360 (370) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES INFORMA PRICE TARGET TO 670 (650) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

SOCGEN RAISES MEGGITT TO 'HOLD' ('SELL') - TARGET 499 (418) PENCE

----------

GOLDMAN SACHS CUTS MEGGITT PRICE TARGET TO 436 (457) PENCE - 'NEUTRAL'

----------

BANK OF AMERICA CUTS MEGGITT PRICE TARGET TO 550 (560) PENCE - 'BUY'

----------

CITIGROUP RAISES COMPUTACENTER PRICE TARGET TO 2,985 (2,600) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES ELEMENTIS PRICE TARGET TO 148 (136) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES 888 HOLDINGS PRICE TARGET TO 460 (420) PENCE - 'BUY'

----------

BARCLAYS CUTS SSP GROUP PRICE TARGET TO 370 (420) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES CONVATEC PRICE TARGET TO 260 (250) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES WH SMITH PRICE TARGET TO 2,200 (1,535) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 590 (515) PENCE - 'OUTPERFORM'

----------

LIBERUM CUTS TRAVIS PERKINS PRICE TARGET TO 1,791 (1,900) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM RAISES HSS HIRE PRICE TARGET TO 21 (12) PENCE - 'HOLD'

----------

BERENBERG RAISES CVS GROUP PRICE TARGET TO 2,400 (2,200) PENCE - 'BUY'

----------

RBC RAISES CVS GROUP PRICE TARGET TO 2,750 (2,400) PENCE - 'OUTPERFORM'

----------

HSBC RAISES KINGSPAN GROUP PRICE TARGET TO 79 (66) EUR - 'HOLD'

----------

BARCLAYS RAISES KERRY GROUP PRICE TARGET TO 131 (130) EUR - 'OVERWEIGHT'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.